Mohd Farid

Mohd Farid

Friday, July 21, 2017

ECG & Echocardiography Case Study Chronic Myocardial Infarction-Credit Cardio Rhythm Online Blogspot

ECG and echo are very useful non-invasive investigations when it comes to assessing patients with a history of myocardial infarction. In ECG terms an old (chronic) myocardial infarction may be characterised by pathological Q waves. In echo terms it may be characterised by regional wall motion abnormalities.

The ECG
Remember it is primarily the ST segments that give us information regarding acute changes, and this can be divided into two main categories: Non-ST Elevation Myocardial Infarction (NSTEMI) and ST Elevation Myocardial Infarction (NSTEMI). 



If Q waves develop this is referred to as a Q-wave infarction, and if no Q waves develop this is sometimes referred to as a non-Q wave infarction. If Q waves do develop they may however resolve due to early treatment, regress, or disappear with time. Q waves may also be electrically silent, meaning they occur in a region where the ECG cannot record the injury. Therefore, not all patients who have an MI develop or show Q waves, and not all Q waves persist. So, given that ST changes typically resolve in time, it is of course possible for someone with a history of MI to have a perfectly normal ECG some stage down the line. That said if Q waves do develop they can remain on the ECG for life. 

A Q wave is a negative deflection that precedes an R wave. Physiologic q waves or “septal” q waves represent normal depolarisation of the septum. They are usually small and commonly seen in the lateral leads. Occasionally you may also see isolated q waves as a normal variant in leads such as III, aVR, and V1. Pathologic Q waves tend to be deeper and wider, and as with ST/T wave changes should be seen in at least 2 contiguous (neighbouring) leads. The general consensus is that loss of electrical forces due to necrosis or scarring of the heart muscle result in the leads (overlying the infarcted area) recording electrical activity from the opposite ventricular wall (moving from an inner to outer direction). The electrical activity is then essentially moving away from these leads at this point and thus creates a negative deflection – the Q wave.

Depending on where the infarction is you may see a Q wave develop before the R wave. In other leads you may note that your R wave has disappeared and the complex becomes a QS wave. 

Be aware though, not all pathologic Q waves are due to MI. Of course, history is crucial. In the event that you have unexpected Q waves (i.e. there is no other evidence of MI) you’ll also need to consider a differential diagnosis such as cardiomyopathy, amyloid, altered conduction (LBBB and WPW), and ventricular enlargement. 










Echocardiography
As a cardiac sonographer I routinely see patients after the diagnosis of an MI has been made and usually after intervention i.e. establishing prognosis. Most acute MIs are apparent on history, ECG, and cardiac enzymes, but an emergency echo may be used to assess regional wall motion abnormalities (RWMAs), which can occur within seconds of a coronary artery occlusion, or to rule out other causes of chest pain (such as aortic dissection) if needed. It is also used to check for any other associated complications such as ventricular septal defect (VSD), papillary muscle rupture, ventricular aneurysms, thrombus, RV wall motion abnormalities, and free wall rupture.

A regional wall motion abnormality is when an area of the ventricle doesn’t contract as well as it should, or doesn’t contract at all. These may be scored or described as being hypokinetic (reduced movement) or akinetic (no movement) – the latter is usually associated with thinning and brightness of the wall i.e. dead muscle. In identifying any hypokinetic/akinetic areas in relation to the remaining normal regions, we can then also comment on how well the left ventricle functions and estimate the ejection fraction – this is the percentage of blood that leaves the left ventricle when it contracts. An ejection fraction of >55% is considered normal LV function. Between 45-54% is considered mildly impaired, 35-45% is moderately impaired, and less than 35% is severely impaired. As with ECG changes, regional wall motion abnormalities caused by myocardial infarction may resolve due to early treatment/reperfusion; this is the situation in what’s known as myocardial stunning.

In the same way that not all pathological Q waves are due to MI, please also bear in mind that not all regional wall motion abnormalities are due to myocardial infarction – other causes include left bundle branch block, RV overload, cardiomyopathy, and prior cardiac surgery.

Lead Groups & Wall Segments
When assessing an ECG we divide our 12-lead into four main contiguous lead groups: inferior, lateral, septal, and anterior. Regions not well represented on a standard 12-lead are the posterior region and the right ventricle; that said, both these regions can be better represented using alternative lead placements, or in the case of posterior infarction looking for reciprocal changes in the right precordial leads.



In echo we assess the left ventricle according to a 17 segment model. The left ventricle is assessed at basal level (6 segments), mid-cavity level (6 segments), and apical level (4 segments) plus the apical cap. This is a parasternal short axis view at mid cavity level – if the views are on axis the LV should appear circular in shape. Just imagine that you have sliced through the ventricles (perpendicular to the septum) and you are looking downwards into the ventricles.  

Just to confuse matters, with regards to terminology, in echo we no longer have posterior segments at all. And, we no longer have pure lateral or septal segments (except at the apex). We have pure anterior and inferior segments, but the septal region is divided into anteroseptal and inferoseptal, and the lateral region is divided into anterolateral and inferolateral (the latter used to be known as posterior). Yep, I know, you like potato and I like potahto…let’s call the whole thing off! Personally I still use the term “posterior” in echo, I tend to write it in brackets – as of yet no one has complained.






Case Study 

Ok, so these days due to primary intervention and preventative measures, life in the echo lab may be a bit lacklustre when it comes to following up myocardial infarctions. I can’t actually remember the last time I saw a ventricular aneurysm. But, signs of a good old-fashioned chronic MI do crop up from time to time – mostly from those who had their infarction some decades back or from those who have had a “silent MI” (a heart attack without any obvious symptoms, usually meaning that medical intervention wasn’t sought early enough). Not to be confused with “electrically silent”. Here is the ECG of a 65 year old male who had an MI in 1993; he has never had coronary intervention. Where do you see evidence of the MI?



Yes that’s right we can see pathological Q waves in leads III and aVF – the inferior region. I would also add that transition is late i.e. occurring after V4 (aka poor R wave progression) and there is also left axis deviation – a common finding in inferior MIs.




Here is the corresponding echo. If you are not used to looking at echo I’ve included a normally functioning LV on the left so that you can compare. The echo on the right shows thinning and akinesia of not just the inferior region, but also the inferolateral (posterior) region. There are also adjacent inferoseptal and anterolateral regions of hypokinesia. Using the Simpsons biplane method the ejection fraction was estimated at 39% - moderately impaired.


If you have trouble watching the video below, especially if you are using Internet Explorer, click  here 




I think what’s interesting about this case study is it demonstrates the limitations of the ECG if trying to estimate infarct size. We see only two Q waves in the inferior leads, and yet perhaps more RWMAs on echo than the ECG suggests. Of course, as already mentioned above, the absence of Q waves could simply imply that a non-Q wave infarction has taken place, that previous Q waves have resolved, or that infarction has occurred in areas that are electrically silent – the latter seems to be particularly true for the posterior and some of the lateral segments. Another reason may be ischaemic hibernating myocardium; this is similar to myocardial stunning in the sense that it exhibits resting wall motion abnormalities due to coronary disease, which then improves if the flow of blood is restored. I try not to get these two terms mixed up, so I always think of “stunning” as being nearer to the event [of an acute MI] lasting only for a short period of time following reperfusion, and “hibernation” as a state of persistently impaired LV function due to ongoing ischaemia. I may have oversimplified all of this somewhat, but the main point is that lack of or absence of Q waves does not rule out LV impairment.

What about RV impairment? It occurred to me whilst writing this that given RV infarction complicates around 40% of inferior MIs I rarely see old RV wall motion abnormalities. The main reason for this is quite simply that the RV is less susceptible to damage due to it being a much smaller chamber with less oxygen demand. Therefore RV function generally improves in the majority of patients even without intervention.

Of course, although echo is a more direct method for measuring the extent of myocardial damage, it too has its limitations. If image quality is poor, visualisation of the endocardium may not be adequate enough to assess all the regions by 2D alone. Contrast echo is useful in these situations. I would also add that to some (or maybe a large) extent it is operator dependent.

I hope you have enjoyed this case study. I have also included some further links below. These case studies are always written from my perspective as a cardiac physiologist and for teaching beginners, so whether you are a beginner or an ECG/echo expert, please feel free to ask questions or to add any further comments in the section below. Thanks for reading. Mx

Saturday, July 15, 2017

Type Of Cardiac Rhythm Management Devices


Type Of Cardiac Rhythm Management Devices



Many cardiac devices are designed to help control irregular heartbeats in people with heart rhythm disorders. These irregularities are caused by problems with the heart’s electrical system, which signals the heart to contract and pump blood throughout the body.

At King Fahd Armed Forces Hospital, Jeddah, our cardiac electrophysiologists implant and monitor devices that either help the heart’s electrical system function properly or measure heart rhythm. These devices will help us to solve a problem with heart rhythm either bradyarrhythmias or tachyarrhtyhmias. These devices include pacemakers, implantable cardioverter defibrillators, or ICDs, and implanted heart rhythm monitors called loop recorders.

Pacemaker






A pacemaker is a small device that’s implanted under the skin of the chest. It produces electrical pulses to keep the heart beating at a normal rate. A pacemaker helps manage heart rhythm disorders, such as bradycardia, when the heart beats too slowly, or an arrhythmia, when the heart beats irregularly.

The size of two half-dollars pressed together, a pacemaker contains a small computer and a battery that are connected to one or two flexible, insulated wires called leads, which extend from the device inside the chest to the heart.

A pacemaker is implanted in the chest, beneath the collarbone during a procedure that requires local anesthesia and sedation. The surgery typically takes less than an hour to complete and usually requires an overnight stay in the hospital.

You can most likely return to your usual activities the day after pacemaker implantation, but your doctor may restrict some activities for two weeks. Restrictions include avoiding lifting anything heavier than 10 pounds and not engaging in exercises such as swimming, golf, or tennis that strain the affected side.

Two weeks after the procedure, your doctor examines the implantation site and checks to see how well the pacemaker is working by using a wand that transmits information stored in the device’s generator to a computer. This includes information about the pacemaker’s battery life, the condition of the lead or leads, and any arrhythmias experienced since the pacemaker was implanted. The battery typically lasts 7 to 13 years.

Every six months, you visit Pacemaker Clinic, so your cardiovascular  technologist or electrophysiologist doctor can retrieve and analyze the information stored on the pacemaker. Sometimes, this information can be transmitted from home via a telephone line, cellular network, or the internet. This scheduled remote monitoring allows for more frequent checkups while reducing the need for office visits to once a year.


Ongoing monitoring helps your doctor determine if the device needs reprogramming or replacing. It can also determine if another therapy, such as medication, is needed to manage a heart rhythm disorder.

King Fahd Armed Forces Hospital, Jeddah offers a new type of pacemaker called a leadless pacemaker. The generator and a small wire are included in the 2-centimeter device, which is implanted directly into the heart via a catheter through a vein.

Biventricular Pacemaker







A biventricular pacemaker works like a conventional pacemaker, but uses a third wire to send electrical impulses to the heart to resynchronize the contractions of the heart’s left lower chamber, or ventricle.

Also called a cardiac resynchronization device, this type of pacemaker is implanted when medications don’t relieve symptoms of heart failure, a condition in which the heart does not pump a sufficient amount of blood to the body, and when the left chamber does not beat in a coordinated manner. This causes both ventricles to contract out of sync with one another. A resynchronization device coordinates the contractions of the left ventricle. Patient with Left Bundle Branch Block ECG morphology wil usually need this type of pacemaker. There is biventricular pacemaker that incorporated with implantable loop recorder as patient with heart failure tend to get tachyarrhytmias such as ventricular tachycardia and ventricular fibrillation.

Doctors provide local anesthesia and a sedative when implanting a biventricular pacemaker. The surgery takes about two hours to complete and requires an overnight stay in the hospital. The restrictions afterward are the same as those recommended after the implantation of a conventional pacemaker.

Your doctor electronically monitors a biventricular pacemaker in the same way as a conventional pacemaker.

Implantable Cardioverter Defibrillator






People with heart failure are often at risk for life threatening, fast, irregular heartbeats called ventricular arrhythmias. These people may need a combination biventricular pacemaker and implantable cardioverter defibrillator, or ICD, which shocks the heart’s rhythm back to normal.

Ventricular arrhythmia occurs when irregular heartbeats originate in the heart’s ventricles, the lower chambers that pump blood to the body. When this happens, the heart stops pumping blood. If the rhythm is not corrected quickly, the result is sudden cardiac arrest, a short-circuiting of the electrical signals that control the heart’s ability to pump blood.

The heart usually pumps out about 60 percent of its blood with each beat, a measurement called ejection fraction. When the heart’s ejection fraction is reduced to 35 percent or less, a person’s risk for sudden cardiac arrest increases. If the reduced ejection fraction is not caused by a condition that can be treated and reversed, surgeons often implant an ICD.

In emergency situations, someone can deliver a shock from an external defibrillator, if one is available, to restore the heart to a normal rhythm. An ICD, however, detects an irregular heartbeat and automatically and internally delivers a series of pacing pulses or an electrical shock to the heart to correct the heart’s rate and rhythm.

An ICD stores information about when and how many electrical shocks are delivered to the heart, whether they corrected the arrhythmia, and the status of the device’s battery. Many ICDs have a built-in pacemaker, which sends electrical impulses to the heart when it is beating too slowly, helping it to beat at a normal rate.

People usually don’t notice small pacing impulses that correct a fast heart rate (Anti Tachycardia Pacing-ATP), but they do feel an uncomfortable “thump” in the chest when a shock is delivered. If you notice one of these shocks, contact your doctor.

The ICD device is surgically implanted in the chest wall below the collarbone. Surgery typically takes about an hour and requires an overnight stay in the hospital. Your doctor may restrict your activity, including driving and lifting items heavier than 10 pounds, until your follow-up appointment 2 weeks after surgery.

If you are at risk of fainting from a fast or irregular heart rhythm, driving may be restricted for longer periods of time or permanently. Your heart condition, not the implanted device, is the reason for this restriction.

The battery for an ICD typically lasts 5 to 10 years.

A new type of defibrillator, called a subcutaneous internal cardioverter defibrillator, is also offered in our hospital. This device does not need to be implanted within the heart or a blood vessel. The leads are implanted subcutaneously, or under the skin, which helps to avoid complications associated with the implantation of a device in a blood vessel.



Implantable Cardiac Loop Recorder



Your cardiac electrophysiologist may recommend surgically implanting a wireless cardiac monitor called a loop recorder, which continuously records your heart’s rhythm for up to three years. Smaller than the size of an AAA battery, this device is surgically inserted beneath the skin of the upper chest to record the heart’s electrical activity, much like an electrocardiogram, or EKG.

People who have had unexplained fainting spells or heart palpitations that can’t be detected by short term heart rhythm recording devices, such as Holter monitors, Rhythm card, King of heart, may be candidates for this device. Doctors may also recommend an implantable loop recorder for people with atrial fibrillation, which causes a rapid and irregular heartbeat. In addition, this device is used in people who have had a stroke for which a cause has not been determined.



Your doctor makes a small incision in the upper chest and inserts the device just under the skin. The surgery is brief, and you can return to your usual activities the next day. Your doctor may limit your activity until the incision heals.

Cardiac loop recorders typically monitor the heart’s electrical activity for up to 36 months before replacement is required. The device is removed through the original incision site through a short surgery that is similar to the implantation procedure.

If you experience a fainting spell or heart palpitations while this device is implanted in the chest, you or another person places a handheld recorder over the device to capture and record the heart’s electrical activity. This information is stored in the device and can be transmitted via a remote monitoring system to help your doctor determine the cause of your symptoms. The loop recorder is also able to automatically record irregular heart rhythms.

The newest implantable cardiac loop recorder is extremely small and can be injected under the skin. In this procedure, a small puncture is made in the skin to the left of the breastbone. The loop recorder is loaded into a small plastic applicator, which your doctor uses to push the device under the skin. Dissolvable sutures are used to close the small puncture. This procedure is performed with local anesthesia, and you can go home afterwards.

Saturday, July 8, 2017

Recommended Echocardiography Protocol For Routine Echocardiography Study-NCL Department, National Heart Institute Malaysia Consensus









Recommended Echocardiography Protocol

Protocol forTransthoracic Echocardiogram (TTE)

Length of clips: 2 cardiac cycles if in sinus rhythm

Parasternal Long Axis View 
2D parasternal long axis at increased depth to visualize extra cardiac structures. CLIP.
If pericardial effussion is present, may give hints as to the underlying pathology. Measure pericardial effusion thickness. CLIP.
When directly visualized, the normal pericardium is no more than 1 to 2 mm in thickness.
If calcific pericardial disease is present, ultrasound shadowing may occur and again give hints as to the underlying pathology. Measure pericardial thickness. CLIP.
Parasternal long axis view at 2/3 of screen without color (descending thoracic aorta not necessary). CLIP.
Zoom Parasternal long axis of Aortic Valve and Mitral Valve. CLIP.
Parasternal long axis with color through Aortic Valve and Mitral Valve. CLIP.
Zoom Left Ventricular Outflow Tract and measure diameter. CLIP.
M-Mode of Aortic Valve and Left Atrium, freeze frame. CLIP.
M-Mode of Left Ventricle and Right Ventricle, freeze frame (cursor through chordae tendinae). CLIP.
Identify abrupt relaxation of the posterior wall with flattening of endocardial motion during diastole.
Identify abnormal septal motion (Represent with early diastolic notching followed by paradoxical and then normal motion of the ventricular septum). Annotate as “abnormal septal motion”. CLIP.
M-Mode measurement if cursor is perpendicular to long-axis of left ventricle. If not, please proceed to 2D measurement. CLIP.
Total clips: 8



2D Measurement if M-mode cursor not perpendicular
Parasternal long axis view with 2D measurements in end diastole while image is frozen (measure interventricular septal thickness, left Ventricular internal dimension in diastole, posterior wall thickness). CLIP.
Parasternal long axis view with 2D measurements in systole while image is frozen (measure left ventricular internal dimension in systole). CLIP.
Total clips: 2

Right Ventricular Inflow View
Right Ventricular Inflow and Tricuspid Valve without color (include Right Ventricular anterior wall motion if possible. CLIP.
Right Ventricular Inflow and Tricuspid Valve with color. CLIP.
Continuous wave Doppler of Tricuspid Regurgitant jet, measure peak velocity for Right Ventricular systolic pressure (freeze image). CLIP.
Total clips 3

Parasternal Short Axis View 
Short axis view at the base of heart to include Aortic valve, Tricuspid valve and Pulmonic valve if possible. CLIP.
Short axis view of Pulmonic Valve and Pulmonary Artery without color (demonstrate bifurcation if possible and assess size relative to aorta). CLIP.
Short axis of Pulmonic Valve and Pulmonary Artery with color. CLIP.
Continuous wave and Pulse wave Doppler of Pulmonic Valve and Pulmonic Insufficiency jet. CLIP.
Zoom Short axis view of Aortic Valve without color. CLIP.
Zoom Short axis view of Aortic Valve with color. CLIP.
Tricuspid Valve without color. CLIP.
Tricuspid Valve with color. CLIP.
Continuous wave Doppler of Tricuspid Regurgitation jet, measure peak velocity for Right Ventricular systolic pressure. CLIP.
Short axis view of Left Ventricle at mitral valve level without color to assess RWMA. CLIP.
Short axis view of Left Ventricle at mid papillary muscle level without color to asses RWMA. CLIP.
Short axis view of Left Ventricular apex. CLIP.
Zoom Short axis view of Mitral valve without color. CLIP.
Zoom Short axis view of Mitral valve with color. CLIP.
Total clips: 15



Apical 4 Chamber
4 Chamber view without color. CLIP.
Apical 4 chamber optimizing the both atria for volume tracing. Measure right and left atrial areas and volumes (using A-L method) at end-systole. CLIP.
M-mode at tricuspid annulus for TAPSE. CLIP.
Measure TDI S’ velocity at tricuspid annulus. CLIP.
4 chamber view with color of Tricuspid Valve. CLIP.
Continuous wave Doppler of Tricuspid Regurgitation jet, measure peak velocity for Right Ventricular systolic pressure. CLIP.
4 Chamber view with color through Mitral Valve. CLIP.
Continuous Wave and Pulse Wave Doppler through Mitral Valve tips with measurement of E velocity, A velocity, E/A ratio and deceleration time. Valsalva maneuver if E/A >1. CLIP.
4 Chamber view with TDI color in frame rate range of 150-220.CLIP.
TDI Pulse Wave Doppler at Mitral valve septal CLIP and lateral annulus CLIP to obtain e’, a’ and s wave, E/e’.
Zoom Left Ventricle optimizing endocardium. (Trace Left Ventricle endocardium in diastole CLIP and systole CLIP using single plane method to determine Left Ventricular ejection fraction).
Zoom LV apex for apical thrombus without color and with color. Adjust focus length.CLIP
Total clips: 16

Apical 5 Chamber
5 Chamber  view without color. CLIP.
5 Chamber view with color through Aortic Valve. CLIP.
Continuous wave Doppler demonstrating Aortic Insufficiency envelope. CLIP.
Continuous wave Doppler demonstrating Aortic Valve stenosis. CLIP.
Pulse wave Doppler of Left Ventricular outflow. CLIP.
Total clips: 5

Apical 2 Chamber
2 Chamber view without color. CLIP.
2 Chamber view with color through Mitral Valve. CLIP.
Zoom Left Ventricle. CLIP.
Total clips: 3

Apical Long Axis
Long axis view without color. CLIP.
Long axis view with color through Aortic Valve and Mitral Valve. CLIP.
Continuous wave Doppler through mitral valve. CLIP.
Continuous wave Doppler through Aortic Valve. CLIP.
Total clips: 4



Subcostal View
4 Chamber view without color. CLIP.
4 Chamber view with color at IAS. CLIP.
Inferior vena cava and Hepatic veins without color. CLIP.
M-mode of IVC with measurements with and without sniff. CLIP.
Total clips: 4

Suprasternal Notch 
Aortic arch without color. CLIP.
Aortic arch with color. CLIP.
Total clips: 2

Grand total clips: 62

Compulsory parameters for report:

1. LV dimensions systole/diastole
2. LV volume in diastole
3. LV wall thickness diastole
4. LVEF
5. Regional wall motion abnormalities (17 segment model)
6. Grade of diastolic function
7. Comment on apical clot
8. RV size
9. RV systolic function
10. TAPSE
11. PW S’
12. Volume of left atrium
13. Volume of right atrium
14. E vel, A vel, Dt, E’, E/E’, E/A, E/A Valsalva
15. Mitral valve comment
16. Aortic valve comment
17. Tricuspid valve comment
18. Pulmonary valve comment
19. Comment on IVS
20. Comment on IAS
21. Comment on pericardium
22. IVC diameter and est RAP
23. Est PAP

Sunday, July 2, 2017

Medtronic Kingdom Of Saudi Arabia Technicians Development Program 2016-2017


Medtronic Kingdom Of Saudi ArabiaTechnicians Development Program 2016-2017



Certificate Of Completion


Overall Result Of Assessment

First Module Assessment Result


Second Module Assessment Result


Medtronic Kingdom Of Saudi Arabia Technicians Development Program



Institution
Medtronic Academy
Supervisor
Yehia Sidani
Lab work
4 Modules Of Pacemaker, ICD and CRT Therapy
Experience
This program walks its attendees through a Journey in CRHF from the very basics of cardiac physiology and arrhythmias, to CRT implant / follow up and Cryo Ablation therapies.

Target audience are mainly entry level technicians / cardiac technologists, and more experienced technicians who would like to refresh their knowledge in this domain.

It is a self-paced 4-Level program, with all material provided on this page, and at the end of every level there will be in-person sessions and assessments. More material will be visible to you as you progress through the levels, and details about the live sessions will be communicated to you via email.

Ø  Module 1-Basic Of Arrhythmia Disorder And Pacing Therapy

o   Introduction To The Heart And The Normal ECG (2 Hours)
o   Sinus Node Dysfunction (2 Hours)
o   AV Node Dysfunction (2 Hours)
o   Reveal DX/XT Overview (0.5 Hour)
o   Pacemaker And ECG (2 Hours)
o   Basic Concepts Of Pacemaker (2 Hours)
o   First Meeting In Riyadh (9th April 2016)
o   First Assessment:98.5%.

Ø  Module 2-ICD Therapy

o   Ventricular Tachyarrhythmias: An Electrophysiology Overview (1.5 Hour)
o   Concepts Of ICD Technology (1.5 Hour)
o   Conducting An ICD Follow Up Using PBL STOP Method (2 Hours)
o   Practicing The Step Of An ICD Follow Up (1.25 Hour)
o   ICD Diagnostic In Practice (1 Hour)
o   ICD Programming Considerations (1.5 Hour)
o   Programming ICDs For Shock Reduction-An Interactive Module (2 Hours)
o   The Phycology Of The ICD Patient (2 Hours)
o   Remote Management Of ICDs (1 Hour)
o   Second Meeting In Riyadh (19th and 20th August 2016)
    • Second Assessment: 93.9%

Ø  Module 3-Heart Failure And CRT Therapy

o   CRT Stages of Care: What Factors Can Improve Response
o   Implantation of a Medtronic CRT System
o   Conducting a CRT Follow-up using PBL-STOP
o   Utilizing Device Diagnostics to Manage the Heart Failure Patient
o   Optimizing CRT Through Device Programming
o   Managing Heart Failure Patients on the CareLink Network
o   Managing CareLink Transmissions
o   Third Meeting In Riyadh (2nd and 4th February 2017)
    • Third Assessment: 100%


Completed One Year Medtronic Technician Development Program training and assessment with High Distinction (97.96%). Got first place in overall assessment.

European Heart Rhythm Association (EHRA) Europace-Cardiostim 2017 Vienna Austria









Alhamdulillah.Regional And International Course And Seminar.Thank You Allah.



  1. 2nd Echo IJN 2010 (Kuala Lumpur)
  2. 6th International Seminar & Workshop on “Improving Healthcare Delivery Through Better Understanding And Applications Of Islamic Medical Ethics Amongst Muslim Medical Professionals” (UIAM, Kuantan)
  3. 2nd Kuala Lumpur Valve Summit 2011-KLVS 2011 (Hilton Hotel, Kuala Lumpur)
  4. ePIC Excellence In The Practice of Cardiovascular Ultrasound Conference 2011 Organized By ASE and Aurora Health Care (Coronado Island Marriot Hotel, San Diego, California, USA)
  5. Asian Training Workshop Organized By National University Health System Singapore, University Of Rochester And Boston Scientific (National University Health System Singapore, Singapore)
  6. American Society Of Echocardiography Scientific Meeting 2013 (Minneapolis, Minnessota, USA)
  7. 3rd Kuala Lumpur Valve Summit 2013-KLVS 2013 and 5th Echo IJN 2013 (Hilton Hotel, Kuala Lumpur)-Faculty
  8. 20th ASEAN Federation Cardiology Congress 2014 (KLCC, Kuala Lumpur)
  9. 24th Annual Congress Of The Association Of Thoracic And Cardiovascular Surgeons Of Asia 2014 (Melia Hotel, Hanoi, Vietnam)
  10. Saudi Arabian Cardiac Interventional Society SACIS 2016 (Dammam, Kingdom Of Saudi Arabia)
  11. Medtronic Technician Development Programme Module 1 Basic Arrhythmias Disorders And Pacing Therapy April 2016 (Riyadh, Kingdom Of Saudi Arabia)
  12. Medtronic Technician Development Programme Module 2 ICD Therapy August 2016 (Riyadh, Kingdom Of Saudi Arabia)
  13. Boston Scientific Regional S-ICD Technician Training (Dubai, United Arab Emirates)
  14. Medtronic Technician Development Programme Module 3  CRT Therapy And Heart Failure February 2017 (Riyadh, Kingdom Of Saudi Arabia)
  15. Gulf Arrhythmias Congress 2017 January 2017 (Riyadh, Kingdom Of Saudi Arabia)
  16. European Heart Rhythm Association Europace Cardiostim 2017 (Vienna, Austria)